Cases & Deals

Bay City Capital fund invests in Aciex

Clients Bay City Capital Fund IV

Jones Day provided advice to Bay City Capital Fund IV in connection with its purchase of Series A-2 Convertible Preferred Stock in a private placement by Aciex, Inc., a developer of therapeutic products for the treatment of eye diseases.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.